148 related articles for article (PubMed ID: 8649785)
21. Familial gastric cancer and Li-Fraumeni syndrome.
Corso G; Pedrazzani C; Marrelli D; Pinto E; Roviello F
Eur J Cancer Care (Engl); 2010 May; 19(3):377-81. PubMed ID: 19674071
[TBL] [Abstract][Full Text] [Related]
22. Detection of both mutant and wild-type p53 protein in normal skin fibroblasts and demonstration of a shared 'second hit' on p53 in diverse tumors from a cancer-prone family with Li-Fraumeni syndrome.
Srivastava S; Tong YA; Devadas K; Zou ZQ; Sykes VW; Chen Y; Blattner WA; Pirollo K; Chang EH
Oncogene; 1992 May; 7(5):987-91. PubMed ID: 1373881
[TBL] [Abstract][Full Text] [Related]
23. TP53 mutation and haplotype analysis of two large African American families.
Hung J; Mims B; Lozano G; Strong L; Harvey C; Chen TT; Stastny V; Tomlinson G
Hum Mutat; 1999; 14(3):216-21. PubMed ID: 10477429
[TBL] [Abstract][Full Text] [Related]
24. Early detection of adrenocortical carcinoma in a child with Li-Fraumeni syndrome.
Lin MT; Shieh JJ; Chang JH; Chang SW; Chen TC; Hsu WH
Pediatr Blood Cancer; 2009 Apr; 52(4):541-4. PubMed ID: 19101993
[TBL] [Abstract][Full Text] [Related]
25. Selective acquisition of IDH1 R132C mutations in astrocytomas associated with Li-Fraumeni syndrome.
Watanabe T; Vital A; Nobusawa S; Kleihues P; Ohgaki H
Acta Neuropathol; 2009 Jun; 117(6):653-6. PubMed ID: 19340432
[TBL] [Abstract][Full Text] [Related]
26. Balanced t(11;15)(q23;q15) in a TP53+/+ breast cancer patient from a Li-Fraumeni syndrome family.
Sherif ZA; Danielsen M
Cancer Genet Cytogenet; 2006 Jul; 168(1):50-8. PubMed ID: 16772121
[TBL] [Abstract][Full Text] [Related]
27. Germline TP53 mutations and Li-Fraumeni syndrome.
Varley JM
Hum Mutat; 2003 Mar; 21(3):313-20. PubMed ID: 12619118
[TBL] [Abstract][Full Text] [Related]
28. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations.
Finkova A; Vazna A; Hrachovina O; Bendova S; Prochazkova K; Sedlacek Z
Cancer Genet Cytogenet; 2009 Aug; 193(1):63-6. PubMed ID: 19602465
[TBL] [Abstract][Full Text] [Related]
29. Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome.
Lee SB; Kim SH; Bell DW; Wahrer DC; Schiripo TA; Jorczak MM; Sgroi DC; Garber JE; Li FP; Nichols KE; Varley JM; Godwin AK; Shannon KM; Harlow E; Haber DA
Cancer Res; 2001 Nov; 61(22):8062-7. PubMed ID: 11719428
[TBL] [Abstract][Full Text] [Related]
30. Screening for TP53 rearrangements in families with the Li-Fraumeni syndrome reveals a complete deletion of the TP53 gene.
Bougeard G; Brugières L; Chompret A; Gesta P; Charbonnier F; Valent A; Martin C; Raux G; Feunteun J; Bressac-de Paillerets B; Frébourg T
Oncogene; 2003 Feb; 22(6):840-6. PubMed ID: 12584563
[TBL] [Abstract][Full Text] [Related]
31. Identification of a novel p53 in-frame deletion in a Li-Fraumeni-like family.
Schiffman JD; Chun N; Fisher PG; Dahl GV; Ford JM; Eggerding FA
Pediatr Blood Cancer; 2008 Apr; 50(4):914-6. PubMed ID: 17554785
[TBL] [Abstract][Full Text] [Related]
32. Li-Fraumeni syndrome in a Malaysian kindred.
Ariffin H; Martel-Planche G; Daud SS; Ibrahim K; Hainaut P
Cancer Genet Cytogenet; 2008 Oct; 186(1):49-53. PubMed ID: 18786442
[TBL] [Abstract][Full Text] [Related]
33. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
[TBL] [Abstract][Full Text] [Related]
34. [When is it useful to look for TP53 germline gene mutations in families of oncology patients?].
Trková M; Sedlácek Z
Cas Lek Cesk; 2003; 142(4):220-5. PubMed ID: 12841124
[TBL] [Abstract][Full Text] [Related]
35. Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families.
Bougeard G; Sesboüé R; Baert-Desurmont S; Vasseur S; Martin C; Tinat J; Brugières L; Chompret A; de Paillerets BB; Stoppa-Lyonnet D; Bonaïti-Pellié C; Frébourg T;
J Med Genet; 2008 Aug; 45(8):535-8. PubMed ID: 18511570
[TBL] [Abstract][Full Text] [Related]
36. Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin.
Bendig I; Mohr N; Kramer F; Weber BH
Cancer Genet Cytogenet; 2004 Oct; 154(1):22-6. PubMed ID: 15381368
[TBL] [Abstract][Full Text] [Related]
37. Two Li-Fraumeni syndrome families with novel germline p53 mutations: loss of the wild-type p53 allele in only 50% of tumours.
Sedlacek Z; Kodet R; Kriz V; Seemanova E; Vodvarka P; Wilgenbus P; Mares J; Poustka A; Goetz P
Br J Cancer; 1998 Apr; 77(7):1034-9. PubMed ID: 9569035
[TBL] [Abstract][Full Text] [Related]
38. A novel TP53 germline mutation in a family with a history of multiple malignancies: case report and review of the literature.
Agarwalla PK; Dunn IF; Turner CD; Ligon KL; Schneider KA; Smith ER
Pediatr Neurosurg; 2008; 44(6):501-8. PubMed ID: 19127094
[TBL] [Abstract][Full Text] [Related]
39. Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation.
Salmon A; Amikam D; Sodha N; Davidson S; Basel-Vanagaite L; Eeles RA; Abeliovich D; Peretz T
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):490-3. PubMed ID: 17572079
[TBL] [Abstract][Full Text] [Related]
40. Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings.
Eeles RA; Warren W; Knee G; Bartek J; Averill D; Stratton MR; Blake PR; Tait DM; Lane DP; Easton DF
Oncogene; 1993 May; 8(5):1269-76. PubMed ID: 8479749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]